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Abstract
Background: Health systems guidance (HSG) provides recommendations to address health systems challenges. No
tools exist to inform HSG developers and users about the components of high quality HSG and to differentiate
between HSG of varying quality. In response, we developed a tool to assist with the development, reporting and
appraisal of HSG – the Appraisal of Guidelines for Research and Evaluation–Health Systems (AGREE-HS). This paper
reports on the validity, usability and initial measurement properties of the AGREE-HS.
Methods: To establish face validity (Study 1), stakeholders completed a survey about the AGREE-HS and provided
feedback on its content and structure. Revisions to the tool were made in response. To establish usability (Study 2),
the revised tool was applied to 85 HSG documents and the appraisers provided feedback about their experiences
via an online survey. An initial test of the revised tool’s measurement properties, including internal consistency,
inter-rater reliability and criterion validity, was conducted. Additional revisions to the tool were made in response.
Results: In Study 1, the AGREE-HS Overview, User Manual, quality item content and structure, and overall
assessment questions were rated favourably. Participants indicated that the AGREE-HS would be useful, feasible to
use, and that they would apply it in their context. In Study 2, participants indicated that the quality items were easy
to understand and apply, and the User Manual, usefulness and usability of the tool were rated favourably. Study 2
participants also indicated intentions to use the AGREE-HS.
Conclusions: The AGREE-HS comprises a User Manual, five quality items and two overall assessment questions. It is
available at agreetrust.org.
Keywords: Health systems guidance, Health system, Health policy, Quality appraisal
Background
Health systems guidance (HSG) provides systematic-
ally developed recommendations to manage challenges
related to health system governance, financial and
delivery arrangements, and the implementation strat-
egies needed to get the right programmes and ser-
vices to those who need them [1–3]. Further, HSG
aims to assist in decision-making, particularly deci-
sions made by health policy-makers, health services
managers, healthcare providers, and system and insti-
tutional leaders [1–3].
There is concern about the quality of HSG docu-
ments that are currently available. These concerns
stem from the recognition of the overall complexity
of health systems and the ability to develop timely,
contextually relevant recommendations; the use of the
broad range of different types of evidence needed to
develop HSG (e.g. evidence generated outside of the
traditional research paradigm); the unique factors that
may influence the design and adoption of recom-
mended actions; and the general lack of experience
and expertise in working with this evidence in a
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systematic and transparent manner [1, 4–7]. The field
of HSG is relatively new; thus, unlike other guidance
fields, such as clinical practice guidelines (CPGs),
there has not yet been enough time to fully cultivate
the best methods for HSG development, reporting
and appraisal [8]. Nonetheless, the risks of varying
quality HSG are not inconsequential. The use of poor
quality HSG to inform decision-making may result in
the adoption of health system arrangements and im-
plementation strategies that are contextually inappro-
priate or ineffective, if not harmful and extremely
costly; this may put populations at harm, waste pre-
cious resources, and undermine the credibility of, and
confidence in, future health system improvement ef-
forts [1, 7].
To help mitigate these risks, an international consor-
tium of researchers, the Appraisal of Guidelines for
Research and Evaluation–Health Systems (AGREE-HS)
Research Team, has undertaken a programme of re-
search aimed at creating a tool to support the develop-
ment, reporting and appraisal of HSG [9]. A critical
interpretive synthesis of the literature was conducted
to identify concepts related to HSG quality that could
serve as criteria for an HSG appraisal tool [10].
Thirty candidate concepts were identified and all were
judged to be important and comprehensive by a sam-
ple of international HSG developers, users (e.g.
policy-makers and a broad range of stakeholders in-
cluding managerial, professional and patient groups)
and researchers; an additional two concepts were rec-
ommended for inclusion [10]. Using these data, a
prototype tool was designed. The 32 concepts were
converted into an item format and linked to one of
four domains. Each of the items had an operational
definition, instructions for use, and the proposed re-
sponse scale. A second international sample of partic-
ipants provided feedback on the prototype tool and
its application [11]. Respondents provided favourable
ratings about the tool’s ease of application and useful-
ness; however, they also offered several suggestions to
improve the tool, including changing the response
scale [11]. Moreover, there was recognition by the Re-
search Team that the application of a 32-item tool
would likely be too time-consuming to make it feas-
ible for most users and that a 7-point response scale,
while preferred, would not be appropriate for many
of the items, given their specificity.
In response, the tool was refined to create the
AGREE-HS Draft, consisting of five core quality items
(topic, participants, methods, recommendations and
implementability). The original 32 items were reframed
as criteria and categorised into one of these five quality
items. The purpose of this article is to describe two
studies designed to test the tool.
Methods
Overview
In Study 1, participants reviewed and systematically
assessed the AGREE-HS Draft, without applying it. In
Study 2, participants used a revised version of the
AGREE-HS Draft (i.e. the AGREE-HS Final Draft) to
appraise a collection of HSG documents; they subse-
quently reflected on their experiences in applying the
AGREE-HS Final Draft. This research was approved
by the Hamilton Integrated Research Ethics Board
(project number: 14–334).
Study 1: Face validity
Participants and process
A purposive sampling strategy was used (rather than
a representative sampling strategy) to optimise vari-
ation in participants’ professional roles and jurisdic-
tions [12]. To this end, a list of international health
systems conference attendees served as the population
from which to draw samples of candidate participants.
This population was complemented by recommenda-
tions from the AGREE-HS Research Team members.
The candidates were categorised based on WHO re-
gion of origin (i.e. Africa, Americas, Eastern Mediter-
ranean, Europe, South-East Asia, Western Pacific)
[13]. Three waves of recruitment enlisted the partici-
pation of individuals that were randomly selected
from each of the six WHO regions; each wave in-
cluded a new batch of candidate participants.
Selected individuals were sent an email invitation that
provided a description of the study and included a link
to the AGREE-HS Draft, a link to the survey and an op-
tion to opt-out of the study. Once participants linked to
the survey platform and their consent was obtained,
each survey generated an anonymous numeric code to
ensure participants’ confidentiality. Participants were
asked to review (but not apply) the AGREE-HS Draft.
They were then asked to complete a survey regarding
their perceptions of the tool.
AGREE-HS draft
The AGREE-HS Draft comprised five quality items
(topic, participants, methods, recommendations, and
implementability), each with a description and series of
criteria. Every item was answered using a 7-point re-
sponse scale (1 = lowest quality to 7 = highest quality),
with higher scores indicating more of the criteria being
met. The AGREE-HS Draft concluded with two overall
assessment questions, as follows: (1) rate the overall
quality of the HSG (1 = lowest quality to 7 = highest
quality) and (2) do you recommend this HSG for use?
(yes, yes with modifications, no).
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Face validity survey
The survey was hosted on the LimeSurvey platform™
and included 26 questions, targeting the following
issues:
 Clarity of the Overview section (1 = strongly
disagree to 7 = strongly agree)
 Perceptions about the User Manual (1 = strongly
disagree to 7 = strongly agree)
 Clarity of content for each of the five quality items
and two overall assessment questions
 Perceptions about the structure of the tool
(1 = strongly disagree to 7 = strongly agree)
 Ranking of importance of the five quality items and
usefulness of the two overall assessment questions
 Usefulness and feasibility of using the tool for HSG
development, reporting and appraisal purposes
(yes – no)
 Participants’ intent to use the tool for HSG
development, reporting and appraisal purposes
(1 = strongly disagree to 7 = strongly agree)
Participants were also encouraged to provide written
feedback.
Analyses
Descriptive statistics (means and standard deviations)
were calculated. While no specific differences between
regions or roles were hypothesised, the number of com-
pleted responses was too low to explore potential differ-
ences. The quantitative data and descriptive feedback
were used to refine wording, structure and the User
Manual instructions. These revisions led to the develop-
ment of the AGREE-HS Final Draft.
Study 2: Usability and testing
Participants and process
A purposive sample of 10 graduate students from
McMaster University (Canada) was recruited to partici-
pate in Study 2. To optimise variation in perspective,
trainees were recruited from three graduate programmes
(i.e. health policy, health research methodology and pub-
lic health). Limited experience and exposure to HSG was
sought to enable a better estimate of the usability of the
tool among its expected users (e.g. junior staff and re-
searchers). Participants attended a practical training ses-
sion to learn about the tool and how to apply it. They
then completed an appraisal for each HSG document
that was allocated to them, using the AGREE-HS Final
Draft. Each document was appraised by two participants
(the results of the appraisals will be available in a separ-
ate publication). Afterwards, participants completed the
Usability survey. All materials and surveys were access-
ible through the LimeSurvey platform™.
HSG
A selection of publicly available HSG was sought for in-
clusion in this study. HSG were eligible if they met the
following criteria:
 Addressed an issue related to health system
governance, financial or delivery arrangements, or
the implementation strategies needed to get the
right programmes and services to those who need
them
 Included recommendations or guidance statements
 Considered published scientific research and/or
local, national or regional data
 Developed by committees from governmental or
non-governmental organisations
 Created for health policy-makers, health systems
stakeholders or researchers
 Published in the English language
 Published between January 2012–March 2017
Databases and directories used to search for HSG were
WHO, the National Institute for Health and Clinical
Excellence (NICE), Health Systems Evidence (healthsys-
temsevidence.org) and a directory of HSG curated by
members of the AGREE-HS Research Team for another
project. Overall, 85 HSG documents met the inclusion
criteria.
AGREE-HS final draft
The AGREE-HS Final Draft was used to appraise the 85
included HSG documents. It comprised the five quality
items included in the previous iteration of the tool, but
with editorial modifications and wording refinements
made in response to feedback received during Study 1. It
concluded with three overall assessment questions:
 Rate the overall quality of this health systems
guidance (1 = lowest quality to 7 = highest quality)
 I would recommend this health systems guidance
for use in the appropriate context (yes, yes with
modifications, no)
 I would recommend this health systems guidance for
use in my context (yes, yes with modifications, no)
Usability survey
The survey was hosted on the LimeSurvey platform™
and consisted of 20 questions, targeting the following
issues:
 Clarity, helpfulness and completeness of the User
Manual (1 = strongly disagree to 7 = strongly agree)
 Appropriateness of level of detail (too much, right
amount, not enough)
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 Overall ease of use and confidence in using the tool
(1 = strongly disagree to 7 = strongly agree)
 Understandability and usefulness of applying each of
the five quality items (1 = strongly disagree to
7 = strongly agree)
 Usefulness of the overall assessment questions
(1 = strongly disagree to 7 = strongly agree)
 Usefulness of the tool for development, reporting
and appraisal purposes and determining whether or
not to use an HSG document
(1 = strongly disagree to 7 = strongly agree)
 Intention to use the tool for development, reporting
and appraisal purposes (1 = strongly disagree to
7 = strongly agree)
Participants were invited to provide written feedback
upon completion of each section of the survey.
Analyses
Usability survey Descriptive statistics (means and stand-
ard deviations) were calculated. Data were used to make
final changes to the tool.
Measurement properties To measure its internal
consistency, Cronbach’s alpha was calculated with the
five quality items [12]. While the study was not specific-
ally powered for this purpose, intraclass correlations
(two-way random model) were calculated between the
ratings for each item to explore inter-rater reliability
[12]. As a surrogate for criterion validation, due to the
absence of an established reference standard, a multiple
linear regression analysis was calculated to determine
which of the five quality items were significant predic-
tors of the overall quality assessment [12].
Results
Study 1: Face validity
Participants
Completed surveys were received from 30 participants,
with representation from each of the WHO regions (18
countries in total) (Table 1). The majority of respondents
were health systems researchers (63%) who had at least
some experience with developing (83%) or implementing
HSG (80%).
Survey results
Table 2 provides an overview of the survey results.
Favourable ratings were found for the components de-
signed to assess the AGREE-HS Draft Overview section
(mean 5.8 to 5.9), User Manual (mean 5.3 to 6.2), item
content (mean 5.6 to 6.0), item structure (mean 5.3 to
5.8), and the assessment questions (mean 5.5 to 5.7).
The majority of respondents indicated that the
Table 1 Study 1 (face validity) participant demographics
Characteristic Frequency
WHO Region Countries represented
Africa Ghana 1
Nigeria 1
Americas Argentina 1
Canada 3
Colombia 1
Peru 1
Eastern Mediterranean Sudan 1
Europe Netherlands 4
Switzerland 1
United Kingdom 2
South-East Asia Bangladesh 2
India 1
Indonesia 3
Thailand 1
Western Pacific Australia 1
China 4
Papua New Guinea 1
Philippines 1
Age, years
< 30 0
30–39 12/30 (40%)
40–49 9/30 (30%)
50–59 5/30 (17%)
60–69 4/30 (13%)
70 or older 0
Professional role/position (multiple responses permitted)
Health policy-maker 5/30 (17%)
Healthcare provider 2/30 (7%)
Healthcare manager or administrator 7/30 (23%)
Health systems researcher 19/30 (63%)
Student 1/30 (3%)
Methodologist 1/30 (3%)
Other (advisor, programme manager) 7/30 (23%)
EXPERIENCE: Developing HSG
No experience 5/30 (17%)
Some experience 18/30 (60%)
Experienced 6/30 (20%)
Very experienced 1/30 (3%)
EXPERIENCE: Applying/Implementing HSG
No experience 6/30 (20%)
Some experience 16/30 (53%)
Experienced 7/30 (23%)
Very experienced 1/30 (3%)
HSG health systems guidance
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AGREE-HS Draft would be useful to assist in how HSG
should be developed, direct what information should be
reported in an HSG document and guide the appraisal
process (73%, 70% and 90%, respectively). Given the
context in which they work, the majority of the respon-
dents also indicated that the AGREE-HS Draft would be
feasible to use in HSG development, to direct its report-
ing and to guide appraisal (60%, 67% and 80%,
respectively). Finally, the participants indicated they
would use the tool to assist in their HSG development
(mean 5.5), reporting (mean 5.7) and appraisal (mean
5.6) activities.
Descriptive feedback
Extensive feedback was provided by participants about
ways to improve the clarity of the AGREE-HS Draft. Key
themes included the need to include minimum thresh-
olds or benchmarks to inform interpretation of the qual-
ity scores, advice on the skills or experience required by
individuals before they engage in applying the tool, and
provision of editorial modifications and examples to
clarify concepts. To prepare for Study 2, only editorial
refinements were made to the AGREE-HS Draft. The
key structure, content and response scale were pre-
served. These minor modifications yielded the
AGREE-HS Final Draft.
Study 2: Usability and testing
Participants
Participants were enrolled in health research method-
ology (n = 4), health policy (n = 3) and public health (n =
3) graduate programmes, and were from a range of
countries of origin. Over half of the participants had no
experience with developing (70%) or implementing HSG
(60%). Participants were between 20 and 50 years old.
Survey results
Table 3 provides a summary of the survey results.
Favourable ratings were found for components designed
to assess the User Manual (mean 5.9 to 6.3), overall as-
sessment questions (mean 5.5 to 6.0), the usefulness of
the tool (mean 5.7 to 6.4) and its usability (mean 5.4 to
6.0). Each of the quality items was rated as easy to
understand (mean 6.0 to 6.6) and easy to apply (mean
5.5 to 6.6). Participants reported strong intentions to use
the AGREE-HS Final Draft for developing and reporting
(mean 6.2), appraising (mean 6.6) and determining the
suitability of HSG for implementation (mean 5.9).
Measurement properties
The internal consistency of the AGREE-HS Final Draft
was acceptable (r = 0.79), with the Cronbach’s alpha in-
creasing to r = 0.85 (i.e. good) with the deletion of the
topic item [14]. Intraclass correlations with two raters
were 0.15, 0.82, 0.73, 0.63 and 0.48 for the topic, partici-
pants, methods, recommendations and implementability
items, respectively. The multiple linear regression ana-
lysis showed that the five quality items could explain
87.3% of the variance of the overall assessment rating.
With the exception of the topic item, all other items
were significant predictors of the overall assessment
rating.
Table 2 Study 1 (face validity) survey results
Component Meana SD
AGREE-HS Overview Section
The ‘Background’ section clearly describes the purpose
of the AGREE-HS
5.9 0.7
The ‘AGREE-HS Items and Criteria’ section clearly
describes how the AGREE-HS is structured
5.7 0.9
The ‘Application of the AGREE-HS’ section clearly
describes who the AGREE-HS is intended for
5.9 0.8
User Manual Instructions
How to use the 7-point response scale is clear 6.1 0.8
How to calculate the overall score is clear 6.1 0.8
How to interpret the overall score is clear 5.2 1.4
Overall, the instructions are clear 5.6 0.9
Based on the instructions, I feel confident about
applying the AGREE-HS tool
5.4 1.2
AGREE-HS Item Content
The content presented on the Topic item page is clear 5.8 1.0
The content presented on the Participants item page
is clear
5.9 1.0
The content presented on the Methods item page
is clear
5.6 1.1
The content presented on the Recommendations item
page is clear
5.9 1.2
The content presented on the Implementability item
page is clear
5.8 1.2
AGREE-HS Item Structure
The structure of the item pages is comprehensive 5.7 1.0
The structure of the item pages is logical 5.8 0.8
The structure, format and content of the item pages
will enable users to appraise the item correctly
5.6 1.0
The level of detail provided on the item pages is
appropriate
5.3 1.0
AGREE-HS Assessment Questions
Rate the overall quality of the HSG
This question is clear 5.5 1.1
This question is useful to include 5.6 1.0
Do you recommend this HSG for use?
This question is clear 5.6 1.1
This question is useful to include 5.7 1.2
aScores are based on a 7-point scale (1 = strongly disagree and
7 = strongly agree)
HSG health systems guidance
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Descriptive feedback
As in Study 1, considerable feedback and recommen-
dations were provided by participants, primarily edi-
torial in nature, to improve the clarity of concepts. In
addition, participants indicated there would be value
in having additional resources available for individuals
less familiar with the tool, to improve confidence in
its application.
Discussion
Actions and refinements
Based on the results of the two studies, five substantive
issues emerged which required action and refinement to
create the final draft of the tool, called the AGREE-HS
(Version 1).
Experience and training
As with any new tool, applying the AGREE-HS becomes
easier with experience. In Study 2, while participants in-
dicated that the AGREE-HS Final Draft’s five quality
items were easy to understand and easy to apply (mean ≥
5.8), ratings were somewhat lower when they were
asked about their confidence in the ratings they assigned
(mean 5.4). The latter finding was also seen in Study 1
and, while no quantitative data exist, anecdotal data con-
firm this experience when the AGREE II tool for CPGs
was released [15]. As part of the overall AGREE research
programme, and in response to these data, the AGREE
Enterprise website will host the AGREE-HS (Version 1)
in addition to a range of resources, tutorials and exam-
ples to optimise its application [9]. This is particularly
important for supporting the development, reporting
and appraisal of the topic item, which may be more con-
text specific and nuanced than the other four
quality items.
For which HSGs?
Some participants from Study 2 questioned whether
some of the documents they were appraising were eli-
gible as HSG. We ensured that formal inclusion criteria
were set and applied by two independent raters; thus, we
have confidence in the documents that were used in the
study. The AGREE-HS Final Draft quality items and cri-
teria identified the explicit information, steps and con-
siderations that should occur in a high quality HSG
development process and that should be reported in a
high quality HSG document. That some documents may
be formatted differently, fail to report information, or be
called by another name, does not make them any less of
an HSG document; rather, they may be of poor quality.
This point has been discussed in the AGREE-HS (Version
1) User Manual. Additionally, an AGREE-HS Reporting
Checklist, which can be used as a resource by the HSG
community to increase capacity and skills, has been devel-
oped by the Research Team (Additional file 1).
Modifications to items
In both studies, the five quality items were rated as clear,
easy to understand and easy to apply. The internal
consistency of the items is acceptable and, while not de-
signed specifically as a reliability study, the results from
Study 2 showed the inter-rater reliability of the items to
be moderate to excellent, with the exception of one item,
topic. Indeed, the topic item also did not predict the
overall quality assessment. For now, this item has been
retained given that this concept has been supported in
all other components of this programme of research. Its
Table 3 Study 2 (usability) survey results
Component Meana SD
Instructions
The AGREE-HS instructions are clear 6.0 0.4
The AGREE-HS instructions are helpful 6.3 0.4
The AGREE-HS instructions are complete 5.9 0.6
Overall Usability
The AGREE-HS is easy to use 6.0 0.6
I am confident with the ratings I assigned 5.4 0.6
Core Items
The item, “Topic” is easy to understand 6.6 0.5
The item, “Topic” is easy to apply 6.6 0.5
The item, “Participants” is easy to understand 6.5 0.5
The item, “Participants” is easy to apply 6.4 0.6
The item, “Methods” is easy to understand 6.2 0.6
The item, “Methods” is easy to apply 6.2 0.6
The item, “Recommendations” is easy to understand 6.1 0.7
The item, “Recommendations” is easy to apply 5.9 0.8
The item, “Implementability” is easy to understand 6.0 0.6
The item, “Implementability” is easy to apply 5.8 0.9
The AGREE-HS is complete; the items address all key
quality components of HSG
5.3 1.4
Overall Assessment Items
The question, “Rate the overall quality of this health
systems guidance” is useful
6.0 1.2
The question, “I would recommend this health systems
guidance for use in the appropriate context” is useful
5.5 1.4
Usefulness
The AGREE-HS would be useful for evaluating HSG 6.4 0.5
The AGREE-HS would be useful for HSG development
and reporting
6.3 1.2
The AGREE-HS would be useful for deciding whether or
not to implement HSG
5.7 0.6
The AGREE-HS adds value to the HSG enterprise 6.4 0.5
aScores are based on a 7-point scale (1 = strongly disagree and
7 = strongly agree)
HSG health systems guidance
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poorer measurement properties may be attributed to it
being more context and experience dependent. That is,
AGREE-HS users may require more experience and un-
derstanding of a particular HSG document to be able to
confidently apply the topic item; therefore, refinement of
this item was made. Additionally, the overall assessment
question, ‘rate the overall quality of this health systems
guidance’, has been removed in the AGREE-HS (Version
1). In its place, users are instructed to calculate an over-
all quality score from the five quality items only, as this
is viewed as a more robust, reliable and valid assessment
of quality.
Scoring instructions
The AGREE-HS tool has been designed to facilitate the
development, reporting and appraisal of HSG docu-
ments. AGREE-HS quality scores can be used to cat-
egorise HSG (see ‘Thresholds and Benchmarking’ below)
or to facilitate discussion and build capacity among users
when their scores do not align. To this end, two scoring
strategies are offered. In situations where the preserva-
tion of the diverse perspectives across appraisers is
prioritised, individual rating scores for each quality item
(and total item scores) can be averaged, and measures of
variance can be derived to reflect this diversity. Alterna-
tively, users may wish to discuss scores in a group set-
ting to create a consensus score for the individual items.
While different in purpose, each option is a legitimate
scoring strategy. Users should be explicit about scoring
methods used and make decisions before the scoring
process begins, given that the choice of strategy may im-
pact the conclusions drawn and the decisions made.
These suggestions are described in the AGREE-HS (Ver-
sion 1).
Thresholds and benchmarking
Participants in both studies indicated the need for add-
itional direction about how item and overall quality
scores should be interpreted. While more research is
required to create empirically derived benchmarks to de-
fine high and low quality HSG, we have offered exam-
ples of how the data can be interpreted. In situations
where classification systems are preferred, users could
perform a tertile split of the overall quality scores of the
candidate HSG documents being considered and then
categorise them within each tertile as higher, moderate
or lower quality documents. Alternatively, users may es-
tablish threshold scores a priori through consensus. For
example, HSG documents with mean total scores above
5.0 may be defined as high quality, mean total scores
below 3.0 may be defined as low quality, and all else de-
fined as medium quality. Finally, users may determine,
again through a priori consensus, that a certain item is
more relevant and important for their decision-making
purposes. As a consequence, they may primarily con-
sider that particular item, determine a threshold, and
use the item’s threshold to differentiate between high and
low quality HSG. For example, applying the AGREE II to
evaluate CPGs, some users focus on the Rigor of Develop-
ment domain and only consider CPGs that meet a cut off
of 70% in that domain to be of high quality, regardless of
the performance in other domains [16]. These examples
are included in the AGREE-HS (Version 1).
Strengths and limitations
A key strength in developing the AGREE-HS (Version 1)
was the diversity among the participants with respect to
geography/jurisdiction, professional roles and experience
with HSG. This diversity is reflected in the membership
of the AGREE-HS Research Team, the individuals who
participated in the two studies reported here and in the
earlier studies [10, 11]. While the absolute number of
participants in Study 1 was relatively small, we are reas-
sured that we captured varied opinions by confirming
regional representation and professional responsibilities.
A second strength of this study was the use of high qual-
ity methods to assess face validity and usability, and to
conduct preliminary testing of measurement properties.
A limitation to these studies, and the programme of
research overall, was that it was almost exclusively con-
ducted within the context of English language HSG and
among English language speakers. While French lan-
guage literature and interviews were considered in earl-
ier stages, we were not consistent in using them
throughout the programme of research. Additionally,
trainees who appraised the HSG documents had varied
level of experience and expertise relating to health policy
and systems. However, they attended a training session
to learn about the AGREE-HS tool and how to apply it.
They were also encouraged to contact the AGREE-HS
team if they encountered any problems while completing
their assigned appraisals.
Next steps and future directions
The AGREE-HS (Version 1) is now released to the
health systems community. The AGREE Enterprise web-
site provides access to the tool and the AGREE-HS
Reporting Checklist, and over time, a range of resources
and training materials to optimise the application of the
tool [9]. Like the AGREE II [16], we will be developing
an interactive training platform and will be encouraging
translations of the AGREE-HS (Version 1) into various
languages. Through its application and feedback, we
hope to gain experience and data to continue to refine
the tool. Ongoing assessment of its measurement prop-
erties will be important. Moreover, as more methodo-
logical and conceptual studies are conducted and are
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published in the literature, the AGREE-HS (Version 1)
must be agile and adapt accordingly.
Conclusions
Like CPGs, HSG is becoming an increasingly important re-
source to promote high quality healthcare and strong
health systems [2]. HSG documents provide actionable rec-
ommendations that can be used by health policy-makers
and stakeholders; however, as with any new health
innovation, methods to optimise their development and
strategies to differentiate between HSG of higher and lower
quality are lacking [1]. Our programme of research was de-
signed to address this gap.
Following international standards of measurement design
and an integrated knowledge translation approach, we con-
ducted a critical interpretive synthesis to generate HSG
quality concepts, developed an initial AGREE-HS proto-
type, and vetted it with an international group of HSG de-
velopers, users, researchers and experts [10, 11]. Using data
from these studies, we refined the prototype to create the
two drafts of the tool (the AGREE-HS Draft and the
AGREE-HS Final Draft), the objects of investigation in the
two studies reported here. In Study 1, we recruited partici-
pants from each of the WHO regions (18 countries) who
provided favourable ratings about the structure, the Over-
view section, the User Manual and the items of the
AGREE-HS Draft. After refinement, the AGREE-HS Final
Draft was applied to 85 HSG documents, and usability test-
ing, as well as testing of the tool’s measurement properties,
was undertaken (Study 2). The results of Study 2 indicated
that the tool is easy to use and that the right amount of in-
struction is provided to users. The initial measurement
properties of the tool were strong and final refinements
were made to create the AGREE-HS (Version 1).
The AGREE-HS (Version 1) is a valid and reliable tool
for HSG appraisal. It comprises a User Manual, five qual-
ity items and two overall assessment questions. The
AGREE-HS does not describe a specific operational
method for HSG development and reporting. Rather, its
quality criteria are meant to serve as a blueprint for HSG
development and reporting; an AGREE-HS Reporting
Checklist has been created to provide a more user-friendly
format of the tool for these purposes (Additional file 1),
and is available on the AGREE Enterprise website [9]. The
AGREE-HS items, along with their definitions and associ-
ated criteria, are available as a supplement to this article
(Additional file 2). The AGREE-HS (Version 1) is available
in its entirety on the AGREE Enterprise website [9].
Additional files
Additional file 1 AGREE-HS Reporting Checklist. (DOCX 683 kb)
Additional file 2 AGREE-HS item information. (DOCX 23 kb)
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